Office of Women’s Health director named

Executive Summary

FDA names Kathleen Uhl as director of the Office of Women's Health, effective Dec. 15. Uhl has been with the Center for Drug Evaluation & Research since 1998, most recently serving as the team leader for the Pregnancy & Lactation Labeling Team in the Office of New Drugs. Uhl will replace Theresa Toigo, who took over as acting director of the women's health office after Susan Wood resigned in protest of FDA's handling of an OTC switch application for Barr's emergency contraceptive Plan B (1"The Pink Sheet" Sept. 6, 2005, p. 6)...